Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
AMB Express ; 14(1): 81, 2024 Jul 16.
Artículo en Inglés | MEDLINE | ID: mdl-39014110

RESUMEN

The issue of antibiotic resistance in pathogenic microbes is a global concern. This study was aimed to explore in silico and in vitro analysis of the antibacterial efficacy of different natural ligands against bacterial activity. The ligands included in the study were Propolis Neoflavanoide 1, Carvacrol, Cinnamaldehyde, Thymol, p-benzoquinone, and Ciprofloxacin (standard drug S*). The outcomes of molecular docking revealed that Propolis Neoflavaniode-1 showed a highly significant binding energy of - 7.1 and - 7.2 kcal/mol for the two gram-positive bacteria, as compared to the gram-negative bacteria. All ligands demonstrated acute toxicity (oral, dermal), except for Propolis Neoflavanoide 1 and S* drugs, with a confidence score range of 50-60%. Using a molecular dynamic simulation approach, we investigated Propolis Neoflavaniode-1's potential for therapeutic use in more detail. An MD simulation lasting 100 ns was performed using the Desmond Simulation software to examine the conformational stability and steady state of Propolis Neoflavaniode-1 in protein molecule complexes. Additionally, in vitro studies confirmed the antimicrobial activity of Propolis Neoflavaniode 1 by increasing the zone of inhibition against Gram-positive bacteria, p < 0.005 as compared to gram-negative bacteria. This study revealed the promising antibacterial efficacy of Propolis Neoflavaniode 1, demonstrated through robust in silico analyses, minimal toxicity, and confirmed in vitro antimicrobial activity, suggesting its potential as a viable alternative to combat antibiotic resistance.

2.
Comput Biol Chem ; 79: 137-146, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30818108

RESUMEN

BACKGROUND/AIM: Main objective of this study is mapping of the anticancer efficacy of synthesized gallic acid analogues using modeling and artificial intelligence (AI) over a large range of concentrations and exposure times to explore the underline mechanisms of drug action and draw careful inferences regarding drug response heterogeneity. METHODS: Two series of gallic acid derivatives i.e. esters and amides have been synthesized and characterized by FTIR, NMR and mass spectrometry. The compounds have been tested in vitro for their anticancer activity against wild type human ovarian cancer cell line A2780, prostate cancer cell line PC3 and normal human fibroblast cells 3T3. To completely characterize optimal anticancer activity, a comprehensive model using piecewise recursive Hill model is used to quantitatively assess the in vitro anticancer effect of the tested compounds as a function of concentration and exposure time for periods ranging from 24 to 72 h. A robust artificial intelligence approach i.e. the "Support Vector Machine (SVM) Learning Algorithm" is adopted to utilize the data obtained at different temporal values, to identify compounds that trail forecasting algorithm. RESULTS: All the synthesized analogues were found biocompatible. Significantly low EC50 values indicated that tested compounds have potent anticancer activity against A2780 cell line in comparison to PC3 cells where only few compounds generated same impact at almost 200 times high dose. On the basis of EC50 values, compounds 7 h, 7 m, 9c, 9b, 7c, 7b and 7 g were identified as the most active anticancer agent against A2780. Three major patterns of drug response heterogeneity were observed for different compounds in the form of multiple Hill graphs and shallow slopes. The anticancer efficiency of the compounds was verified using Machine learning SVM regression learner algorithm. For compounds 7a, 7b, 7e, 7 g, 7o, 7 r, 9b, 9e-9 g higher accuracy was found in predicted and experimentally obtained end point potency in terms of % viability. CONCLUSIONS: Pharmacodynamics modeling of anticancer potential of the synthesized compounds revealed that drug efficacy and response heterogeneity could be modulated by changing the exposure time to optimize therapeutic impact. Combining experimental results with AI based drug action forecasting, compounds 7b, 7 g, and 9b may be tested further as potent anticancer agent for in vivo studies. This approach may serve a useful tool for extrapolation of in vitro results for generating lead compounds in in vivo and preclinical studies.


Asunto(s)
Antineoplásicos/química , Antineoplásicos/farmacología , Inteligencia Artificial , Ácido Gálico/química , Ácido Gálico/farmacología , Algoritmos , Antineoplásicos/síntesis química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Ácido Gálico/análogos & derivados , Humanos , Aprendizaje Automático , Modelos Moleculares , Estructura Molecular , Células PC-3 , Relación Estructura-Actividad , Máquina de Vectores de Soporte , Factores de Tiempo
3.
J Membr Biol ; 247(4): 345-55, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24573306

RESUMEN

Brevibacterium linens (B. linens) DSM 20158 with an unsequenced genome can be used as a non-pathogenic model to study features it has in common with other unsequenced pathogens of the same genus on the basis of comparative proteome analysis. The most efficient way to kill a pathogen is to target its energy transduction mechanism. In the present study, we have identified the redox protein complexes involved in the electron transport chain of B. linens DSM 20158 from their clear homology with the shot-gun genome sequenced strain BL2 of B. linens by using the SDS-Polyacrylamide gel electrophoresis coupled with nano LC-MS/MS mass spectrometry. B. linens is found to have a branched electron transport chain (Respiratory chain), in which electrons can enter the respiratory chain either at NADH (Complex I) or at Complex II level or at the cytochrome level. Moreover, we are able to isolate, purify, and characterize the membrane bound Complex II (succinate dehydrogenase), Complex III (menaquinone cytochrome c reductase cytochrome c subunit, Complex IV (cytochrome c oxidase), and Complex V (ATP synthase) of B. linens strain DSM 20158.


Asunto(s)
Proteínas Bacterianas/química , Brevibacterium/química , Proteínas del Complejo de Cadena de Transporte de Electrón/química , Complejos de ATP Sintetasa/química , Complejos de ATP Sintetasa/aislamiento & purificación , Adenosina Difosfato/química , Proteínas Bacterianas/genética , Proteínas Bacterianas/aislamiento & purificación , Brevibacterium/genética , Citocromos c/química , Citocromos c/aislamiento & purificación , Proteínas del Complejo de Cadena de Transporte de Electrón/genética , Proteínas del Complejo de Cadena de Transporte de Electrón/aislamiento & purificación , Transferencia de Energía , Genoma Bacteriano , Cinética , Oxidación-Reducción , Fosfatos/química , Vitamina K 2/química , Vitamina K 2/aislamiento & purificación
4.
Pharm Biol ; 51(3): 383-90, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23406359

RESUMEN

CONTEXT: In the course of searching hepatoprotective agents from natural sources, the protective effect of chemical constituents of the marine brown alga Spatoglossum variabile Figaro et DE Notar (Dictyoaceae) against CCl4-induced liver damage in Wistar rats was investigated. The compounds were first investigated for in vitro radical scavenging potential and were also tested for ß-glucuronidase inhibition to further explore the relationship between hepatoprotection and antiradical potential. METHODS: The compounds cinnamic acid esters 1 and 2 and aurone derivatives 3 and 4 were first investigated for in vitro radical scavenging potential against 1,1-diphenyl-2-picrylhydrazyl radicals (DPPH), and superoxide anion radicals. In vivo hepatoprotective studies were performed in seven groups (n = 6) of Wistar rats. The test groups were pretreated with compounds (10 mg/kg body weight, po) orally for 30 min before the intraperitoneal administration of a dose of 20% CCl4 diluted with dietary cooking oil. Moreover, compounds were also tested for ß-glucuronidase inhibition to explore the relationship between hepatoprotection and radical scavenging potential. RESULTS: The test compounds 1-4 were found to exhibit antiradical activity against 1,1-diphenyl-2-picrylhydrazyl radicals with IC50 values ranging between 54 and 138 µM, whereas aurone derivatives 3 and 4 additionally exhibited superoxide anion scavenging effects with IC50 values of 95 and 87 µM, respectively. In addition, these compounds were found to be weak inhibitors of xanthine oxidase (IC50 ≥1000 µM). In animal model, pretreatment with compounds 2-4 significantly blocked the CCl4-induced increase in the levels of the serum biochemical markers. CONCLUSION: It appears that the hepatoprotection afforded by these compounds was mainly due to their radical scavenging activity that protected the cells from the free radicals generated by CCl4-induced hepatotoxicity.


Asunto(s)
Benzofuranos/uso terapéutico , Intoxicación por Tetracloruro de Carbono/prevención & control , Cinamatos/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Hígado/efectos de los fármacos , Phaeophyceae/química , Animales , Benzofuranos/efectos adversos , Benzofuranos/química , Benzofuranos/farmacología , Biomarcadores/sangre , Intoxicación por Tetracloruro de Carbono/sangre , Intoxicación por Tetracloruro de Carbono/fisiopatología , Supervivencia Celular/efectos de los fármacos , Cinamatos/efectos adversos , Cinamatos/química , Cinamatos/farmacología , Descubrimiento de Drogas , Inhibidores Enzimáticos/efectos adversos , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Inhibidores Enzimáticos/uso terapéutico , Proteínas de Escherichia coli/antagonistas & inhibidores , Depuradores de Radicales Libres/efectos adversos , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Glucuronidasa/antagonistas & inhibidores , Humanos , Hígado/fisiopatología , Masculino , Proteínas de la Leche/antagonistas & inhibidores , Neutrófilos/efectos de los fármacos , Ratas , Ratas Wistar , Xantina Oxidasa/antagonistas & inhibidores
5.
Nat Prod Res ; 17(4): 247-51, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12822902

RESUMEN

Emodinol, a new oleane type triterpene, has been isolated from the chloroform soluble fraction of Paeonia emodi. The structure 1beta, 3beta, 23-trihydroxyolean-12-en-28-oic acid 1 has been assigned on the basis of spectral studies including 2D NMR. It showed significant beta-glucuronidase inhibitory activity. In addition benzoic acid and 3-hydroxybenzoic acid have also been reported for the first time from this species.


Asunto(s)
Glucuronidasa/antagonistas & inhibidores , Ácido Oleanólico/aislamiento & purificación , Ácido Oleanólico/farmacología , Paeonia/química , Triterpenos/aislamiento & purificación , Triterpenos/farmacología , Glucuronidasa/metabolismo , Espectroscopía de Resonancia Magnética , Estructura Molecular , Ácido Oleanólico/análogos & derivados , Ácido Oleanólico/química , Triterpenos/química
6.
Nat Prod Res ; 17(3): 159-63, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12737398

RESUMEN

Steam distilled oil of Cymbopogon citratus was analyzed by Gas Chromatographic-Mass Spectrometry (GC-MS) and citral was found as major constituent. The oil exhibited significant inhibition of beta-glucuronidase activity and also showed activities against some tested human, plant and animal pathogens. The minimum inhibitory concentrations could not be determined due to the lack of some chemicals.


Asunto(s)
Cymbopogon/química , Aceites Volátiles/química , Aceites Volátiles/farmacología , Cromatografía de Gases y Espectrometría de Masas , Glucuronidasa/antagonistas & inhibidores , Glucuronidasa/farmacología , Humanos , Pruebas de Sensibilidad Microbiana
7.
Chem Pharm Bull (Tokyo) ; 50(11): 1443-6, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12419907

RESUMEN

Eight new beta-N-substituted acyl hydrazides along with their corresponding acyl derivatives were synthesized and screened for in vitro beta-glucuronidase inhibition and found to be active against the enzyme. All of these compounds were found to be noncompetitive inhibitors except for N'-(2-cyanoethyl)-4-hydroxy benzohydrazide (10), which was found to be an uncompetitive inhibitor. Structure-activity relationship studies indicated that the benzyloxy group present in compounds 12 and 13 is responsible for the beta-glucuronidase inhibition activity.


Asunto(s)
Glucuronidasa/antagonistas & inhibidores , Glicoproteínas/química , Hidrazinas/química , Animales , Bovinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA